The rat dermorphin-like immunoreactivity is supported by an aminopeptidase resistant peptide

Journal of Neuroimmunology

Volumn 81, Issue 1-2, 1998, Pages 211-224

  Cucumel, K ^a   Bagnol, D ^b   Moinier, D ^a   Fischer, J ^c   Conrath, M ^c   Cupo, A ^a  

^a INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b CNRS   (France)

^c SORBONNE UNIVERSITÉ   (France)

Author keywords

Aminopeptidase resistance; Dermorphin like immunoreactivity; Gut; HPLC characterization; Immune tissues; Pituitary gland; Radioimmunoassay; Site directed dermorphin antibodies

Indexed keywords

AMINOPEPTIDASE; ENDORPHIN;

ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; ENZYME INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOREACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RADIOIMMUNOASSAY; RAT; T LYMPHOCYTE;

AMINOPEPTIDASES; ANIMALS; BRAIN CHEMISTRY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLON; DIGESTIVE SYSTEM; ENDOPEPTIDASES; GUINEA PIGS; IMMUNOENZYME TECHNIQUES; LYMPHOCYTE SUBSETS; MALE; MICE; MICE, INBRED BALB C; NERVE TISSUE PROTEINS; NEUROIMMUNOMODULATION; NEURONS; NEUROPEPTIDES; OLIGOPEPTIDES; OPIOID PEPTIDES; ORGAN SPECIFICITY; PEPTIDE FRAGMENTS; PERIPHERAL NERVES; PITUITARY GLAND; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; SPECIES SPECIFICITY; SPLEEN;

EID: 0031809469     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00182-3     Document Type: Article

References (72)

1. 2] deltorphin in amacrine cells of rat retina. Peptides. 15:1994;49-54.
2. Bagnol D., Mansour A., Akil H., Watson S.J. Localization of μ and κ opioid receptors in rat colon by antibodies to the cloned opioid receptors. Analgesia. 1:1995;264-267.
3. Bagnol, D., Mansour, A., Takahashi, T., Reinscheid, R., Civelli, O., Owyang, O., Akil, H., Watson, S.J., 1996. Distribution of Orphanin FQ peptide in rat and guinea-pig gastrointestinal tract: Comparison with met-enkephalin and dynorphin 1-17 peptides. Annual Meeting for the Society of Neurosciences, Washington DC.
4. Brantl V., Gramsch C., Lottpeich F., Henschen A., Jeager K.H., Herz A. Novel opioid peptides derived from hemoglobin: hemorphins. Eur. J. Pharmacol. 125:1986;309-310.
5. Broccardo M., Ersparmer V., Falconeri-Erparmer G., Improta G., Linari G., Melchiorri P., Montecucchi P.C. Pharmacological data on dermorphins, a new class of potent opioid peptides from amphibian skin. Br. J. Pharmacol. 73:1981;625-631.
6. Broccardo M., Improta G., Nargi M., Melchiorri P. Effects of dermorphin on gastrointestinal transit in rats. Regul. Pept. 4:1982;91-96.
7. Buffa R., Solcia E., Magnoni E., Rindi G., Negri L., Melchiorri P. Immunohistochemical demonstration of a dermorphin-like peptide in rat brain. Histochemistry. 76:1982;273-276.
8. Carpentier S., Sagan S., Delfour A., Nicolas P. Dermenkephalin and deltorphin 1 reveal similarities within ligand-binding domains of μ and δ-opioid receptors and an additional address subsite on the δ receptor. Biochem. Biophys. Res. Commun. 3:1991;1161-1168.
9. Carr D.J. The role of endogenous opioids and their receptors in the immune system. Proc. Soc. Exp. Biol. Med. 198:1991;710-720.
10. Carr D.J., Rogers T.J., Weber R.J. The relevance of opioids and opioid receptors on immunocompetence and immune homeostasis. Proc. Soc. Exp. Biol. Med. 213:1996;248-257.
11. Carraway R.E., Singer E.A., Ferris C.F., Mitra S.P. Generation of immunoreactive neurotensin(s) and enkephalin(s) by pepsine-treatment of plasma. Adv. Exp. Med. Biol. 4:1986;169-179.
12. 2): A potent and specific agonist for morphine (μ) receptor. Science. 212:1981;75-77.
13. Chavkin C., Goldstein A. Specific receptor for the opioid peptide dynorphin: Structure-activity relationship. Proc. Natl. Acad. Sci. USA. 78:1981;6543-6547.
14. Cucumel K., Garreau I., Méry J., Moinier D., Mansour A., Akil H., Cupo A. Production and characterization of site directed antibodies against dermorphin and dermorphin-related peptides. Peptides. 17:1996;973-982.
15. -16 mole levels. J. Neuroimmunol. 8:1985;57-67.
16. Cupo A., Vion-Dury J., Jarry T. A new immunization procedure for the obtention of antileucine enkephalin antibodies. Part I. Immunization procedure and physicochemical characterization of antibodies. Neuropeptides. 8:1986;207-219.
17. Dores R.M., McDonald L.K., Stevenson T.C., Sei C.A. The molecular evolution of neuropeptides: Prospects for the 90 s. Brain Behav. Evol. 36:1990;80-99.
18. 2 (Tyr-W-MIF-1). Peptides. 13:1992;623-631.
19. Erspamer V. The opioid peptides of the amphibian skin. Int. J. Dev. Neurosci. 10:1992;3-30.
20. Ferre J., Du C., Soldani G., Ruckebusch Y. Peripheral versus central components of the effects of derporphin on intestinal motility in the fed rat. Regul. Pept. 13:1986;109-117.
21. Fickel J., Bagnol D., Watson S.J., Akil H. Opioid receptor expression in the rat gastro-intestinal tract: A quantitative study with comparison to the brain. Mol. Brain. Res. 46:1997;1-8.
22. Furness, J.B., Costa, M., 1987. The enteric nervous system. In: Furness, J.B., Costa, M. (Eds.), Churchill Livingston. p. 290.
23. Furness J.B., Costa M., Murphy R., Beardsley A.M., Oliver J.R., Llewellyn-Smith I.J., Eskay A.B., Shulkes A.B., Moody T.W., Meyer D.M. Detection and characterization of neurotransmitters, particularly, in the gastrointestinal tract. Scand. J. Gastroenterol. 17:1982;61-70.
24. Garreau I., Cucumel K., Dagouassat N., Zhao Q., Cupo A., Piot J.M. Hemorphin peptides are released from hemoglobin by cathepsin D. Radioimmunoassay against the C-part of V-V-hemorphin-7: An alternative assay for the cathepsin D activity. Peptides. 18:1997;293-300.
25. Garreau I., Pejoan C., Bressolier P., Verneuil B., Cucumel K., Cupo A. Purification and characterization of enkephalin-related peptides released by in vitro peptic digestion of bovine plasma proteins. Peptides. 15:1994;1195-1204.
26. Garreau I., Zhao Q., Pejoan C., Sannier F., Cupo A., Piot J.M. VV-hemorphin-7 and LVV-hemorphin-7 released during in vitro peptic hemoglobin hydrolysis are morphinomimetic peptides. Neuropeptides. 28:1995;243-250.
27. Gergen K.A., Zadina J.E., Paul D. Analgesic effects of Tyr-W-MIF1: A mixed μ2-opioid receptor agonist/μ1-opioid receptor antagonist. Eur. J. Pharmacol. 316:1996;33-38.
28. Gintzler A.R., Adapa I.D., Toll L., Medina V.M., Wang L. Modulation of enkephalin release by nociceptin (orphanin FQ). Eur. J. Pharmacol. 325:1997;29-34.
29. Glämsta E.L., Marklund A., Hellman U., Wernstedt C., Terenius L., Nyberg F. Isolation and characterization of a hemoglobin-derived opioid peptide from the human pituitary gland. Regul. Pept. 34:1991;169-179.
30. Goldstein A., Tachibana S., Lowney L.I., Hunkpapiller M., Hood L. Dynorphin (1-13) an extraordinarily potent opioid peptide. Proc. Natl. Acad. Sci. USA. 76:1979;6666-6670.
31. Grisel J.E., Mogil J.S., Belknap J.K., Grandy D.K. Orphanin FQ acts as a supraspinal, but not a spinal, anti-opioid peptide. Neuro Report. 7:1996;2125-2129.
32. Guillemin R., Link N., Burgus R. Endorphines: Peptides d'origine hypothalamique et neurohypophysaire à activité morphinomimétique. Isolement et structure moléculaire de l'endorphine. C.R. Acad. Sci. 282:1976;783-785.
33. Hackler L., Kastin A.J., Erchegyi J., Zadina J.E. Isolation of Tyr-W-MIF-1 from bovine hypothalami. Neuropeptides. 24:1993;159-164.
34. 2). Peptides. 15:1994;945-950.
35. Herbrecht F., Bagnol D., Cucumel K., Julé Y., Cupo A. Biochemical characterization and quantification of enkephalins in brain, prevertebral ganglia and digestive tract: A comparative study on cats, guinea-pigs and rats. Regul. Pept. 57:1995;85-95.
36. Hökfelt T. Neuropeptides in perspective the last ten years. Neuron. 7:1991;867-879.
37. Horvath A., Kastin A.J. Isolation of tyrosine-melanocyte-stimulating hormone release-inhibiting factor 1 from bovine brain tissue. J. Biol. Chem. 264:1989;2175-2179.
38. Hugues J., Smith T., Morgan B., Fothergill L. Purification and properties of enkephalin: The possible endogenous ligand for the morphine receptor. Life Sci. 16:1975;1753-1758.
39. Kastin A.J., Zadina J.E., Olson R.D., Banks W.A. The history of neuropeptide research: Version 5a. Ann. N.Y. Acad. Sci. 780:1996;1-18.
40. Kreil G., Barra D., Simmaco M., Ersparmer V., Falconieri-Ersparmer G., Negri L., Severini C., Corsi R., Melchiorri P. Deltorphin, a novel amphibian skin peptide with high selectivity and affinity for δ opioid receptors. Eur. J. Pharmacol. 162:1989;123-128.
41. Kromer W. Endogenous and exogenous opioids in the control of gastrointestinal motility and secretion. Pharmacol. Rev. 40:1988;121-162.
42. La Regina A., Petrillo P., Sbacchi M., Tavani A. Interaction of U-69,593 with mu, delta and kappa opioid binding sites in analgesic and intestinal effects in rats. Life Sci. 42:1988;293-301.
43. Meunier J.C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., Butour J.L., Guillemot J., Ferrara P., Montserrat B., Mazarguil H., Vassart G., Parmentier M., Costentin J. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature. 377:1995;532-535.
44. Miller, R.J., Hirning, L.D., 1989. Opioid peptides of the gut. In: Schultz, S.T., Malklouf, G.M., Raunereds, B.B. (Eds.), Handbook of Physiology: The Gastrointestinal System. Bethesda, pp. 631-660.
45. Mogil J.S., Grisel J.E., Reinscheid R.K., Civelli O., Belknap J.K., Grandy D.K. Orphanin FQ is a functional anti-opioid peptide. Neuroscience. 75:1996;333-337.
46. Mogil J.S., Grisel J.E., Zhang G.E., Belknap J.K., Grandy D.K. Functional antagonism of μ-, δ- and κ-opioid antinociception by Orphanin FQ. Neurosci. Lett. 214:1996;1-4.
47. Mor A., Delfour A., Amiche M., Sagan S., Nicolas P., Grassi J., Pradelles P. Dermorphin and related peptides in rat tissues. Neuropeptides. 13:1989;51-57.
48. Mor A., Delfour A., Nicolas P. Identification of a D-alanine containing polypeptide precursor for the peptide opioid, dermorphin. J. Biol. Chem. 266:1991;6264-6270.
49. Mor A., Delfour A., Sagan S., Amiche M., Pradelles P., Rossier J., Nicolas P. Isolation of dermenkephalin from amphibian skin, a high affinity δ selective opioid heptapeptide containing a D-amino acid residue. FEBS Lett. 255:1989;269-274.
50. Mor A., Pradelles P., Delfour A., Montagne J.J., Quintero F.L., Conrath M., Nicolas P. Evidence for pro-dermorphin processing products in rat tissues. Biochem. Biophys. Res. Commun. 170:1990;30-38.
51. Myers R.D. Neuroactive peptides: Unique phase in research on mammalian brain over the three decades. Peptides. 15:1994;381-567.
52. Portoghese P.S. Bivalent ligands and the message-address concept in the design of selective opioid antagonists. Trends Pharmacol. Sci. 10:1989;230-235.
53. Portoghese P.S. The design of delta selective opioid receptor antagonists. Farmaco. 48:1993;243-251.
54. Reed G.W. The tyr-MIF-1 family of peptides. Neurosci. Biobehav. Rev. 18:1994;519-525.
55. Reinscheid R.K., Nothacker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., Grandy D.K., Langen H., Monsma F.J., Civelli O. Orphanin FQ: A neuropeptide that activates an opioid-like G protein-coupled receptor. Science. 270:1995;792-794.
56. Richter K., Egger R., Kreil G. D-Alanine in the frog skin peptide dermorphin is derived from L-alanine in the precursor. Science. 238:1987;200-202.
57. Rossi A., Di Salle E., Briatico G., Arcari G., De Castiglione R., Perseo G. Antinociceptive, prolactin releasing and intestinal motility inhibiting activities of dermorphin and analogues after subcutaneous administration in the rat. Peptides. 4:1983;577-580.
58. Sagan S., Amiche M., Delfour A., Camus A., Mor A., Nicolas P. Differential contribution of the terminal regions of dermorphin and dermenkephalin to opioid-sites selection and binding potency. Biochem. Biophys. Res. Commun. 163:1989;726-732.
59. Schell M.J., Brady R.O., Molliver M.E., Snyder S.H. D-Serine as a neuromodulator: Regional and developmental localization in rat brain glia resemble NMDA receptors. J. Neurosci. 17:1997;1604-1615.
60. Schell M.J., Cooper O.B., Snyder S.H. D-aspartate localizations imply neuronal and neuroendocrine roles. Proc. Natl. Acad. Sci. USA. 94:1997;2013-2018.
61. Schultzberg M., Hökfelt T., Nilsson G., Terenius L., Rehfeld J.F., Brown M., Elde R.P., Goldstein M., Said S. Distribution of peptide-and catecholamine-containing neurons in the gastro-intestinal tract of rat and guinea-pig: Immunohistochemical studies with antisera to substance P vasoactive intestinal polypeptide, enkephalins, somatostatin, gastrin/cholecystokinin, neurotensin and dopamine β hydroxylase. Neuroscience. 5:1980;689-744.
62. Stefanini M., De Martino C., Zamboni L. Fixation of ejaculated spermatozoa for electron microscopy. Nature. 216:1967;173-174.
63. Stefano G.B., Scharrer B., Smith E.M., Hugues T.K., Magazine H.I., Bilfinger T.V., Hartman A.R., Fricchione G.L., Liu Y., Makman M.H. Opioid and opiate immunoregulatory processes. Crit. Rev. Immunol. 16:1996;109-144.
64. Tavani A., Petrillo P., La Regina A., Sbacchi M. Role of peripheral mu, delta and kappa opioid receptor in opioid-induced inhibition of gastrointestinal transit in rats. J. Pharmacol. Exp. Ther. 254:1990;91-97.
65. Tsou K., Wang F.S., Wang S.H., Tang Y.Q. Dermorphin-like immunoreactivity in guinea-pig and rat stomach. Neuropeptide. 5:1985;449-452.
66. Vion-Dury J., Cupo A., Jarry T. Analgesic properties of valproic acid might be related to activation of proenkephalin system in rat brain. Brain Res. 408:1987;243-246.
67. Watson S.J., Akil H., Ghazarossian E., Goldstein A. Dynorphin immunocytochemical localization in brain and peripheral nervous system: Preliminary studies. Proc. Natl. Acad. Sci. USA. 78:1981;1260-1263.
68. Werner Reed G., Olson G.A., Olson R.D. The Tyr-MIF-1 family of peptides. Neurosci. Biobehav. Rev. 18:1994;519-525.
69. Wolter H. Alpha-melanocortin and beta-endorphin-like immunoreactivities are contained within neurons and nerve fibers of the rat duodenum. Brain Res. 295:1984;378-384.
70. Zadina J.E., Hackler L., Ge L.J., Kastin A.J. A potent and selective endogenous agonist for the μ-opiate receptor. Nature. 386:1997;499-502.
71. Zadina J.E., Kastin A.J., Kersh D., Wyatt A. Tyr-MIF-1 and hemorphin can act as opiate agonists and as antagonists in the guinea pig ileum. Life. Sci. 51:1992;869-885.
72. 2) and related peptides to μ1 and μ2 opiate receptors. Neurosci. Lett. 215:1996;65-69.